Similar articles

• Fluorescent approaches to diagnosis of Lesch-Nyhan syndrome and quantitative analysis of carrier status.

  Mansfield ES, Blasband A, Kronick MN, Wrabetz L, Kaplan P, Rappaport E, Sartore M, Parrella T, Surrey S, Fortina P. Mansfield ES, et al. Mol Cell Probes. 1993 Aug;7(4):311-24. doi: 10.1006/mcpr.1993.1045. Mol Cell Probes. 1993. PMID: 8232348
• Screening for molecular pathologies in Lesch-Nyhan syndrome.

  Boyd M, Lanyon WG, Connor JM. Boyd M, et al. Hum Mutat. 1993;2(2):127-30. doi: 10.1002/humu.1380020212. Hum Mutat. 1993. PMID: 8318989
• A recurrent large Alu-mediated deletion in the hypoxanthine phosphoribosyltransferase (HPRT1) gene associated with Lesch-Nyhan syndrome.

  Mizunuma M, Fujimori S, Ogino H, Ueno T, Inoue H, Kamatani N. Mizunuma M, et al. Hum Mutat. 2001 Nov;18(5):435-43. doi: 10.1002/humu.1214. Hum Mutat. 2001. PMID: 11668636
• Molecular analysis of mutation at the human hprt locus.

  Lambert B, Andersson B, He SM, Hellgren D, Marcus S, Steen AM. Lambert B, et al. Acta Physiol Scand Suppl. 1990;592:85-92. Acta Physiol Scand Suppl. 1990. PMID: 2267946 Review. No abstract available.
• Molecular genetics of hypoxanthine-guanine phosphoribosyltransferase deficiency in man.

  Wilson JM, Kelley WN. Wilson JM, et al. Arch Intern Med. 1985 Oct;145(10):1895-1900. Arch Intern Med. 1985. PMID: 3899038 Review. No abstract available.